HOME 
Archive Life Sciences Archive Lung device pioneer seeks backer
Archive Life Sciences Archive Lung device pioneer seeks backer | Lung device pioneer seeks backer |
| Written by Lautaro Vargas | |
| Wednesday, 12 December 2007 | |
 Innovation in action: From left, Simon Talbot, P3 Medical; Dr Sunit Ghosh, consultant anaesthetist, Papworth; David Strong, medical director, Papworth; Stephen Bridge, chief executive, Papworth and Tony Tomstone, P3 Medical. It has a potential usage in emergencies involving the armed forces as well as in general A & E. Created by Dr Sunit Ghosh, the Papworth BiVent Endotracheal Tube allows ventilation to one lung to be stopped whilst maintaining ventilation of the other. It enhances surgical access dramatically reducing the time from intubation to lung isolation, provides protection against contamination by infected debris and fluid spreading from one lung to the other and enables greater stability compared to conventional endotracheal tubes thus benefiting patients during surgical procedures. Dr Ghosh was helped to develop the device by Health Enterprise East, the region’s NHS innovation hub, also based at Papworth Hospital. Through its network of contacts within the healthcare industry, HEE was able to access a suitable commercial partner – P3 Medical Ltd. HEE senior innovation manager, Stuart Thomson said: “Around 500,000 surgical procedures requiring lung isolation are carried out worldwide each year and this number is likely to increase with the growing demand for thoracic surgery as diagnostic and therapeutic procedures evolve. “It is hoped this double lumen tube will be very helpful in general surgical procedures requiring access to structures in the chest and also in situations where rapid lung isolation is required such as in A&E or the armed forces.” Dr Alistair Grant, senior R & D manager, said a commercial partner was crucial to making the Papworth BiVent available for patients. He said: “Large scale trials of the clinical and cost-effectiveness of the new tube will build on the Trust’s reputation for patient-focused innovation, research and development and help support adoption of the product in the NHS and other markets.” |
Delicious
Digg
NewsVine
Reddit
Technorati| < Prev | Next > |
|---|
Advertisement
Site Login
 |